Teva’s transformation under new CEO Richard Francis is taking another turn. Wednesday, the company confirmed plans to sell its active pharmaceutical ingredients business as part of Francis’ “pivot to ...

The world’s number two producer of active pharmaceutical ingredients (APIs) is for sale. Given the constant global demand for essential medicines, the business might seem like a lucrative asset. But ...

Increasingly, APIs are being accessed by autonomous systems capable of deciding how and when to interact with those APIs.​ ...

Less than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business.

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Workato®, the leading AI-driven enterprise orchestration platform, announced the launch of its Unified API Platform, designed to empower enterprises to publish, ...

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...

Teva announced its intention to divest its active-pharmaceutical ingredient business, or "TAPI". TAPI is a global leader in the small-molecule API industry, with approximately 4,300 employees ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Boomi™, the intelligent integration and automation leader, today announced the launch of the Boomi API Control Plane — providing enterprises with a centralized ...